LATEST ARTICLES
- Temperature Controlled Logistics in Biopharmaceuticals Europe 2023
- Clinical Trial Supply Europe 2023
- Johnson & Johnson defends bankruptcy play in appeals court, but plaintiffs call it a ‘bad faith’ move
- Seagen’s Tukysa picks up FDA priority review after Merck buyout talks said to sputter
- Spectrum, Oncopeptides’ oncology drugs have much to overcome heading into FDA adcomm
